急性心肌梗死并发心源性休克的临床治疗分析

目的探究急性心肌梗死并发心源性休克的临床治疗分析。方法选择2008年3月～2011年3月期间笔者所在医院收治的80例急性心肌梗死并发心源性休克患者,随机平均分为观察组和对照组各40例。对照组6h内给予溶栓治疗,观察组给予经皮冠状动脉介入术治疗。结果两组在肌钙蛋白I、LVEF得分差异无统计学意义(P>0.05)。观察组有效25例,占62.5%,明显高于对照组有效19例,占47.5%,两组比较差异有统计学意义(P<0.05)。观察组死亡15例,占37.5%,明显低于对照组死亡21例,占52.5%,两组比较差异有统计学意义(P<0.05)。结论临床发生急性心肌梗死并发心源性休克病情凶险,预后较差,尽管采用溶栓和PCI治疗但死亡率仍较高,PCI治疗的有效率较溶栓治疗的有效率高,值得临床应用与推广。

Analysis of clinical treatment of acute myocardial infarction complicated by cardiogenic shock

Objective To investigate the clinical analysis of acute myocardial infarction complicated by cardiogenic shock.Methods From March 2008 to March 2011 in the author’s hospital,80 cases of patients with acute myocardial infarction complicated by cardiogenic shock were randomly divided into observation group and control group,40 cases given thrombolytic therapy in the control group.The observation group were treated with percutaneous coronary intervention treatment for 6 hours.Results There were no significant differences in troponin Ⅰ and LVEF score,no statistically significant(P > 0.05).25 cases of observation group,accounting for 62.5%,significantly higher than the effective 19 cases,accounting for 47.5% compared the two groups were comparable(P < 0.05).In the observation group,15 cases died,accounting for 37.5%,significantly lower than the control group of 21 cases of death,accounting for 52.5% compared two groups were comparable(P < 0.05).Conclusion The clinical occurrence of acute myocardial infarction complicated by cardiogenic shock dangerous disease,the prognosis is poor,despite the use of thrombolysis and PCI treatment,but mortality is still high,and treated with PCI efficiency compared with thrombolytic therapy have higher efficiency,it is worth clinical application and promotion.